Delivery Order SPE2DB22D2009-SPE2DB25FM0KS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mupirocin 2% Ointment in 22-gram units with a ceiling value of $2,633.58. This firm fixed price contract, awarded on September 9, 2025, represents a non-set-aside competitive award with an ultimate completion date of September 10, 2025. The product will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office headquarters. This delivery order is issued...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Mupirocin 2% Ointment in 22-gram units, with a contract ceiling value of $5,614.00 and a firm fixed price. The award was competitively procured without set-aside designation and is scheduled for completion by August 22, 2025. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,824.59 to AmerisourceBergen Drug Corp for Mupirocin 2% Ointment in 22-gram units, with a completion date of September 8, 2025. This is a firm fixed price, non-set-aside delivery order issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered...
- The Defense Logistics Agency awarded a $3,448.43 delivery order to AmerisourceBergen Drug Corp for Mupirocin 2% Ointment (22 GM) on September 9, 2025, with completion expected by September 10, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,837.43 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Mupirocin 2% Ointment in 22-gram units. This is a firm fixed price delivery order with no set-aside designation, completed under open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This delivery order represents a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Mupirocin 2% Ointment in 22-gram units, with a ceiling value of $2,900.42. This firm fixed price delivery order, awarded on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a continuation of the company's role as a critical pharmaceutical supplier to federal medical procurement needs. The contract utilizes no set-aside designation and will be performed...
- The Defense Logistics Agency awarded a delivery order valued at $3,938.97 to AmerisourceBergen Drug Corp for Mupirocin 2% Cream in 15-gram quantities. This competitively awarded, firm fixed-price delivery order was issued on August 29, 2025, with an ultimate completion date of September 2, 2025. The contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,542.84 to AmerisourceBergen Drug Corp for the supply of Mupirocin 2% Cream in 15-gram units. This contract, awarded on August 7, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 8, 2025. The award was not designated as a set-aside contract, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,085.74 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,565,800,626 units of Mupirocin 2% Ointment (22 g). This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of pharmaceutical and medical supplies to support military treatment...
- The Defense Logistics Agency awarded a delivery order valued at $5,101.00 to AmerisourceBergen Drug Corp for the supply of Mupirocin 2% Cream in 30-gram units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 10, 2025. The award was issued on September 9, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0KSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Mupirocin 2% Ointment in 22-gram units, valued at $2,145.58. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 23, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's competitively awarded contract portfolio demonstrates its capability to fulfill federal medical supply requirements across multiple therapeutic domains through flexible delivery order arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/22/25 |